FDA Draft Guidance on Importing FDA-Approved Prescription Drugs

Summary

The FDA has released a draft guidance for industry on importing certain FDA-approved human prescription drugs, including biological products, under Section 801(d)(1)(B) of the Federal Food, Drug, and Cosmetic Act. The guidance aims to provide an additional avenue for lower-cost drugs in the U.S. market, addressing challenges faced by manufacturers.